Targeted Immunomodulation in Psoriasis: Emerging progress on biologics and small molecules.
Psoriasis is a chronic immune-mediated inflammatory skin disorder that affects more than 125 million people worldwide. A dysregulation in the multiple immune signaling pathways involving innate and adaptive immune cells, leads to persistent inflammation and epidermal hyperproliferation in psoriasis. Hyperactivation of...